World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan
Shots:
- On Aug 21- 2020- CureApp receives MHLW’s approval for the manufacturing and sale of Asia’s first therapeutics app- the “CureApp SC Nicotine Addiction Treatment App and CO Checker’’. The company plans to receive insurance reimbursement and release CureApp SC in FY2020
- CureApp SC is a prescription medical device designed to aid patients receiving outpatient smoking cessation treatment and supports patients to quit smoking in a home setting. The product consists of three components - a patient app- a doctor app- and a portable CO Checker
- The patient app can provide personalized guidance and is used in tandem with the portable CO Checker- allowing patients to accurately measure the concentration of CO in their breath at home. The patient’s condition obtained from the patient app and the CO Checker will be shared with doctors via the doctor app
Ref: PRNewswire | Image: PRNewswire
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com